Skip to main content
Premium Trial:

Request an Annual Quote

German Genome Center, Company to Combine Gene-Expression Services

NEW YORK, March 11 (GenomeWeb News) - The RZPD German Resource Center for Genome Research plans to combine its Affymetrix GeneChip services with the cell-type expression-profiling technology made by German neighbor Axaron Bioscience, the groups said today.


Axaron, based in Heidelberg, and Berlin-based RZPD intend to co-market their services in future, they said.


RZPD, an authorized Affymetrix partner, provides Affy services throughout Europe. Axaron sells its Axaminer service for gene-expression profiling. The technology comprises specific cell labeling, automated cell isolation using laser microdissection, isolation, and RNA amplification.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.